Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec 19;61(12):e0090323.
doi: 10.1128/jcm.00903-23. Epub 2023 Nov 28.

Trichophyton indotineae and other terbinafine-resistant dermatophytes in North America

Shawn R Lockhart  1 , Dallas J Smith  1 , Jeremy A W Gold  1
Affiliations
Comment

Trichophyton indotineae and other terbinafine-resistant dermatophytes in North America

Shawn R Lockhart et al. J Clin Microbiol. .

Abstract

Dermatophyte infections (a.k.a. ringworm, tinea) affect an estimated 20%-25% of the world's population. In North America, most dermatophytoses are caused by Trichophyton rubrum or Trichophyton mentagrophytes species complexes. Severe and antifungal-resistant dermatophytoses are a growing global public health problem. A new species of the T. mentagrophytes species complex, Trichophyton indotineae, has recently emerged and is notable for the severe infections it causes, its propensity for antifungal resistance, and its global spread. In this issue of the Journal of Clinical Microbiology, C. F. Cañete-Gibas, J. Mele, H. P. Patterson, et al. (J Clin Microbiol 61:e00562-23, 2023, https://doi.org/10.1128/JCM.00562-23) summarize the results of speciation and AFST performed on North American dermatophyte isolates received at a fungal diagnostic reference laboratory. Within their collection, 18.6% of isolates were resistant to terbinafine (a first-line oral antifungal for dermatophytoses), and similar proportions of T. rubrum and T. indotineae demonstrated terbinafine resistance. The authors also found that T. indotineae has been present in North America since at least 2017. These findings highlight the importance of increased surveillance efforts to monitor trends in severe and antifungal-resistant dermatophytoses and the need for antifungal stewardship efforts, the success of which is contingent upon improving laboratory capacity for dermatophyte speciation and AFST.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Havlickova B, Czaika VA, Friedrich M. 2008. Epidemiological trends in skin mycoses worldwide. Mycoses 51 Suppl 4:2–15. doi:10.1111/j.1439-0507.2008.01606.x - DOI - PubMed
    1. Hainer BL. 2003. Dermatophyte infections. Am Fam Physician 67:101–108. - PubMed
    1. Foster KW, Ghannoum MA, Elewski BE. 2004. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 50:748–752. doi:10.1016/s0190-9622(03)02117-0 - DOI - PubMed
    1. Mushtaq S, Faizi N, Amin SS, Adil M, Mohtashim M. 2020. Impact on quality of life in patients with dermatophytosis. Australas J Dermatol 61:e184–e188. doi:10.1111/ajd.13191 - DOI - PubMed
    1. Benedict K, Whitham HK, Jackson BR. 2022. Economic burden of fungal diseases in the United States. Open Forum Infect Dis 9:ofac097. doi:10.1093/ofid/ofac097 - DOI - PMC - PubMed

MeSH terms

Supplementary concepts